Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz, Alcon and Advanced Accelerator Applications to learn about our generics, eye care and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A C D E F G I J K L M N O P R S T U V X Z

Tyzeka®/Sebivo™

telbivudine
Infectious disease
Established Medicines
Global Product Site USA Germany United Kingdom Poland Canada Turkey

Tyverb®

lapatinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Trileptal®

oxcarbazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Travatan® BAK-Free

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan Z®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Tobradex®

tobramycin, dexamethasone
Ophthalmology
Ophthalmology
USA Germany Austria Poland Netherlands Canada

TOBI® Podhaler™

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

TOBI®

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tegretol®

carbamazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tasigna®

nilotinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Tafinlar®

dabrafenib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan